237 related articles for article (PubMed ID: 10737887)
21. Towards the optimization of drug delivery to the cochlear apex: Influence of polymer and drug selection in biodegradable intracochlear implants.
Lehner E; Honeder C; Knolle W; Binder W; Scheffler J; Plontke SK; Liebau A; Mäder K
Int J Pharm; 2023 Aug; 643():123268. PubMed ID: 37488058
[TBL] [Abstract][Full Text] [Related]
22. PEGylated J591 mAb loaded in PLGA-PEG-PLGA tri-block copolymer for targeted delivery: in vitro evaluation in human prostate cancer cells.
Moffatt S; Cristiano RJ
Int J Pharm; 2006 Jul; 317(1):10-3. PubMed ID: 16713147
[TBL] [Abstract][Full Text] [Related]
23. Bone morphogenetic protein but not transforming growth factor-beta enhances bone formation in canine diaphyseal nonunions implanted with a biodegradable composite polymer.
Heckman JD; Ehler W; Brooks BP; Aufdemorte TB; Lohmann CH; Morgan T; Boyan BD
J Bone Joint Surg Am; 1999 Dec; 81(12):1717-29. PubMed ID: 10608383
[TBL] [Abstract][Full Text] [Related]
24. Preparation of gelatin microparticles by co-lyophilization with poly(ethylene glycol): characterization and application to entrapment into biodegradable microspheres.
Morita T; Horikiri Y; Suzuki T; Yoshino H
Int J Pharm; 2001 May; 219(1-2):127-37. PubMed ID: 11337173
[TBL] [Abstract][Full Text] [Related]
25. PLGA Microparticles Entrapping Chitosan-Based Nanoparticles for the Ocular Delivery of Ranibizumab.
Elsaid N; Jackson TL; Elsaid Z; Alqathama A; Somavarapu S
Mol Pharm; 2016 Sep; 13(9):2923-40. PubMed ID: 27286558
[TBL] [Abstract][Full Text] [Related]
26. In vitro release of levonorgestrel from phase sensitive and thermosensitive smart polymer delivery systems.
Chen S; Singh J
Pharm Dev Technol; 2005; 10(2):319-25. PubMed ID: 15926681
[TBL] [Abstract][Full Text] [Related]
27. Development and in vitro characterization of vascular endothelial growth factor (VEGF)-loaded poly(DL-lactic-co-glycolic acid)/poly(ethylene glycol) microspheres using a solid encapsulation/single emulsion/solvent extraction technique.
King TW; Patrick CW
J Biomed Mater Res; 2000 Sep; 51(3):383-90. PubMed ID: 10880080
[TBL] [Abstract][Full Text] [Related]
28. Controlled release of bioactive TGF-beta 1 from microspheres embedded within biodegradable hydrogels.
DeFail AJ; Chu CR; Izzo N; Marra KG
Biomaterials; 2006 Mar; 27(8):1579-85. PubMed ID: 16140372
[TBL] [Abstract][Full Text] [Related]
29. Microencapsulation of dissociable human growth hormone aggregates within poly(D,L-lactic-co-glycolic acid) microparticles for sustained release.
Kim HK; Park TG
Int J Pharm; 2001 Oct; 229(1-2):107-16. PubMed ID: 11604263
[TBL] [Abstract][Full Text] [Related]
30. Why does PEG 400 co-encapsulation improve NGF stability and release from PLGA biodegradable microspheres?
Péan JM; Boury F; Venier-Julienne MC; Menei P; Proust JE; Benoit JP
Pharm Res; 1999 Aug; 16(8):1294-9. PubMed ID: 10468034
[TBL] [Abstract][Full Text] [Related]
31. Protein encapsulation into biodegradable microspheres by a novel S/O/W emulsion method using poly(ethylene glycol) as a protein micronization adjuvant.
Morita T; Sakamura Y; Horikiri Y; Suzuki T; Yoshino H
J Control Release; 2000 Dec; 69(3):435-44. PubMed ID: 11102683
[TBL] [Abstract][Full Text] [Related]
32. Lysozyme release and polymer erosion behavior of injectable implants prepared from PLGA-PEG block copolymers and PLGA/PLGA-PEG blends.
Vesna Milacic VM; Schwendeman SP
Pharm Res; 2014 Feb; 31(2):436-48. PubMed ID: 23959854
[TBL] [Abstract][Full Text] [Related]
33. Biodegradable polymeric microparticles for drug delivery and vaccine formulation: the surface attachment of hydrophilic species using the concept of poly(ethylene glycol) anchoring segments.
Coombes AG; Tasker S; Lindblad M; Holmgren J; Hoste K; Toncheva V; Schacht E; Davies MC; Illum L; Davis SS
Biomaterials; 1997 Sep; 18(17):1153-61. PubMed ID: 9259512
[TBL] [Abstract][Full Text] [Related]
34. The effect of lauryl capping group on protein release and degradation of poly(D,L-lactic-co-glycolic acid) particles.
Samadi N; Abbadessa A; Di Stefano A; van Nostrum CF; Vermonden T; Rahimian S; Teunissen EA; van Steenbergen MJ; Amidi M; Hennink WE
J Control Release; 2013 Dec; 172(2):436-43. PubMed ID: 23751568
[TBL] [Abstract][Full Text] [Related]
35. Preparation of protein loaded poly(D,L-lactide-co-glycolide) microparticles for the antigen delivery to dendritic cells using a static micromixer.
Wischke C; Lorenzen D; Zimmermann J; Borchert HH
Eur J Pharm Biopharm; 2006 Apr; 62(3):247-53. PubMed ID: 16288857
[TBL] [Abstract][Full Text] [Related]
36. Raloxifene-/raloxifene-poly(ethylene glycol) conjugate-loaded microspheres: A novel strategy for drug delivery to bone forming cells.
Kavas A; Keskin D; Altunbaş K; Tezcaner A
Int J Pharm; 2016 Aug; 510(1):168-83. PubMed ID: 27343363
[TBL] [Abstract][Full Text] [Related]
37. Controlled release of drugs from injectable in situ formed biodegradable PLGA microspheres: effect of various formulation variables.
Jain RA; Rhodes CT; Railkar AM; Malick AW; Shah NH
Eur J Pharm Biopharm; 2000 Sep; 50(2):257-62. PubMed ID: 10962236
[TBL] [Abstract][Full Text] [Related]
38. Water-free microencapsulation of proteins within PLGA microparticles by spray drying using PEG-assisted protein solubilization technique in organic solvent.
Mok H; Park TG
Eur J Pharm Biopharm; 2008 Sep; 70(1):137-44. PubMed ID: 18515053
[TBL] [Abstract][Full Text] [Related]
39. Degradation behaviour of block copolymers containing poly(lactic-glycolic acid) and poly(ethylene glycol) segments.
Penco M; Marcioni S; Ferruti P; D' Antone S; Deghenghi R
Biomaterials; 1996 Aug; 17(16):1583-90. PubMed ID: 8842362
[TBL] [Abstract][Full Text] [Related]
40. Formulation and characterization of injectable poly(DL-lactide-co-glycolide) implants loaded with N-acetylcysteine, a MMP inhibitor.
Desai KG; Mallery SR; Schwendeman SP
Pharm Res; 2008 Mar; 25(3):586-97. PubMed ID: 17891553
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
